{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T13:45:07Z","timestamp":1774014307476,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00520-023-07717-3","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T09:02:54Z","timestamp":1681290174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6"],"prefix":"10.1007","volume":"31","author":[{"given":"Hira","family":"Mian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolie","family":"Ringash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette E.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Djurfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane N.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Pater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingshu E.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Prica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"issue":"17","key":"7717_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","volume":"372","author":"J Radford","year":"2015","unstructured":"Radford J, Illidge T, Counsell N et al (2015) Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma. N Engl J Med 372(17):1598\u20131607","journal-title":"N Engl J Med"},{"issue":"16","key":"7717_CR2","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","volume":"35","author":"MPE Andr\u00e9","year":"2017","unstructured":"Andr\u00e9 MPE, Girinsky T, Federico M et al (2017) Early positron emission tomography response\u2013adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial. J Clin Oncol 35(16):1786\u20131794","journal-title":"J Clin Oncol"},{"issue":"6","key":"7717_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.6004\/jnccn.2020.0026","volume":"18","author":"RT Hoppe","year":"2020","unstructured":"Hoppe RT, Advani RH, Ai WZ et al (2020) Hodgkin lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. J Natl Compr Canc Netw 18(6):755\u2013781","journal-title":"J Natl Compr Canc Netw"},{"key":"7717_CR4","unstructured":"Surveillance, Epidemiology and End Results Program. SEER Fact Sheets: Hodgkin\u2019s lymphoma. https:\/\/seer.cancer.gov\/statfacts\/html\/hodg.html. Accessed June 10, 2021."},{"key":"7717_CR5","unstructured":"International Health Conference Constitution of the World Health Organization. Bull World Health Organ. 2002;80(12):983-4."},{"issue":"1","key":"7717_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12955-016-0515-6","volume":"14","author":"N Linendoll","year":"2016","unstructured":"Linendoll N, Saunders T, Burns R et al (2016) Health-related quality of life in Hodgkin lymphoma: a systematic review. Health Qual Life Outcomes 14(1):114","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"7717_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1023\/A:1008315525997","volume":"10","author":"JH Loge","year":"1999","unstructured":"Loge JH, Abrahamsen AF, Ekeberg O et al (1999) Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncol 10(1):71\u201377","journal-title":"Ann Oncol"},{"issue":"16","key":"7717_CR8","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1016\/j.ejca.2006.08.006","volume":"42","author":"F Mols","year":"2006","unstructured":"Mols F, Vingerhoets AJ, Coebergh JW et al (2006) Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study. Eur J Cancer 42(16):2794\u20132801","journal-title":"Eur J Cancer"},{"issue":"18","key":"7717_CR9","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1200\/JCO.2003.01.044","volume":"21","author":"PA Ganz","year":"2003","unstructured":"Ganz PA, Moinpour CM, Pauler DK et al (2003) Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 21(18):3512\u20133519","journal-title":"J Clin Oncol"},{"issue":"12","key":"7717_CR10","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1470-2045(09)70258-X","volume":"10","author":"N Heutte","year":"2009","unstructured":"Heutte N, Flechtner HH, Mounier N et al (2009) Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 10(12):1160\u20131170","journal-title":"Lancet Oncol"},{"issue":"25","key":"7717_CR11","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1200\/JCO.19.03160","volume":"38","author":"S Kreissl","year":"2020","unstructured":"Kreissl S, Muller H, Goergen H et al (2020) Health-related quality of life in patients with Hodgkin lymphoma: a longitudinal analysis of the German Hodgkin study group. J Clin Oncol 38(25):2839\u20132848","journal-title":"J Clin Oncol"},{"issue":"21","key":"7717_CR12","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1200\/JCO.2005.09.085","volume":"23","author":"RM Meyer","year":"2005","unstructured":"Meyer RM, Gospodarowicz MK, Connors JM et al (2005) Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol 23(21):4634\u20134642","journal-title":"J Clin Oncol"},{"issue":"5","key":"7717_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1111961","volume":"366","author":"RM Meyer","year":"2012","unstructured":"Meyer RM, Gospodarowicz MK, Connors JM et al (2012) ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. N Engl J Med 366(5):399\u2013408","journal-title":"N Engl J Med"},{"issue":"5","key":"7717_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"key":"7717_CR15","unstructured":"The EORTC QLQ-C30 scoring manual. Available https:\/\/qol.eortc.org\/manuals\/. Accessed April 14."},{"issue":"1","key":"7717_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139\u2013144","journal-title":"J Clin Oncol"},{"issue":"1","key":"7717_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks K, King MT, Velikova G et al (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 29(1):89\u201396","journal-title":"J Clin Oncol"},{"issue":"2","key":"7717_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejca.2004.10.017","volume":"41","author":"D Osoba","year":"2005","unstructured":"Osoba D, Bezjak A, Brundage M et al (2005) Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer 41(2):280\u2013287","journal-title":"Eur J Cancer"},{"key":"7717_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejca.2018.11.024","volume":"107","author":"S Nolte","year":"2019","unstructured":"Nolte S, Liegl G, Petersen MA et al (2019) General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States. Eur J Cancer 107:153\u2013163","journal-title":"Eur J Cancer"},{"key":"7717_CR20","doi-asserted-by":"crossref","unstructured":"Ilie G, Bradfield J, Moodie L et al (2019) The role of response-shift in studies assessing quality of life outcomes among cancer patients: a systematic review. Front Oncol:9","DOI":"10.3389\/fonc.2019.00783"},{"issue":"27","key":"7717_CR21","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1200\/JCO.2008.20.0634","volume":"27","author":"KS Courneya","year":"2009","unstructured":"Courneya KS, Sellar CM, Stevinson C et al (2009) Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol 27(27):4605\u20134612","journal-title":"J Clin Oncol"},{"issue":"1","key":"7717_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0959-8049(02)00483-5","volume":"39","author":"LM Oldervoll","year":"2003","unstructured":"Oldervoll LM, Kaasa S, Knobel H et al (2003) Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors--results from a pilot study. Eur J Cancer 39(1):57\u201363","journal-title":"Eur J Cancer"},{"issue":"1","key":"7717_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/bjh.15640","volume":"184","author":"JL Crombie","year":"2019","unstructured":"Crombie JL, LaCasce AS (2019) Current considerations in AYA Hodgkin lymphoma. Br J Haematol 184(1):72\u201381","journal-title":"Br J Haematol"},{"issue":"1","key":"7717_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/bjc.2012.550","volume":"108","author":"K Behringer","year":"2013","unstructured":"Behringer K, Muller H, Gorgen H et al (2013) Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group. British Journal of Cancer 108(1):49\u201357","journal-title":"British Journal of Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07717-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T09:04:24Z","timestamp":1684227864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07717-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["7717"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07717-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"14 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HM: Consultancy\/Honoraria fees from Celgene, Takeda, Janssen, Amgen, Sanofi, Research funding Janssen. BC: None. JR: None. RM: None. AH: Research funding from Merck, Seattle Genetics, AbbVie, Roche-Genentech, Karyopharm. LS: None. MD: None. JP: None. JS: None. AP: Honoraria from Astra-Zeneca and Kite Gilead. JNW: Merck, honoraria and research support.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"256"}}